← Open Payments lookup

MARIA VALDEZ: Open Payments

NPI 1982704565 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,490 in 56 payments from 29 companies in 2025. Trend: 2023 $1,297 · 2024 $2,398 · 2025 $2,490

Food & beverage: $1,309Long term medical supply or device loan: $1,000Education: $181
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$1,021
AstraZeneca Pharmaceuticals LP3$242
JAZZ PHARMACEUTICALS INC.2$143
Tempus AI, Inc1$126
Janssen Biotech, Inc.6$104
SEAGEN INC.1$93
Incyte Corporation1$88
Takeda Pharmaceuticals U.S.A., Inc.2$84
Merck Sharp & Dohme LLC3$67
Daiichi Sankyo Inc.2$53

Products named: KISQALI, ZEPZELCA, LYNPARZA, XT CDX, IMFINZI, FRUZAQLA, KEYTRUDA, Enhertu.

Industry payments across TX — which companies pay providers there.